Sabriya Stukes

Sabriya Stukes

Partner & Chief Science Officer atSOSVNY

Sabriya Stukes is a Partner at SOSV NY. She previously held operations and academic roles, including at Stellate Therapeutics and The City College of New York, and holds a PhD in Biomedical Sciences.

What Sabriya can write

Writes checks of$500K to $1M
Comes in atPre-seedCan lead the round
Ownership target10-12%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

SOSV writes $500K to $1M checks, larger than 71% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: SOSV.

Career

  1. The City College of New York · founding Associate Director for the Master’s in Translational Medicine (MTM) program
  2. Stellate Therapeutics · Operations Director
  3. SOSV NY · Partner
  4. SOSV · Partner & Chief Science Officer
    Now

Focus

microbiome-derived therapeuticstranslational medicinehealthcare innovationstem educationscience communication

Education

Albert Einstein College of Medicine, PhD in Biomedical Sciences

Also at SOSV

Partners like Sabriya

At firms with a similar stage, sector and check size.

Alert me when SOSV is active

One email when Sabriya's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Sabriya Stukes?

Sabriya Stukes is a Partner at SOSV NY. She previously held operations and academic roles, including at Stellate Therapeutics and The City College of New York, and holds a PhD in Biomedical Sciences.

How much does Sabriya Stukes invest?

Sabriya Stukes invests through SOSV, which writes checks of $500K to $1M at pre-seed.

How do I pitch Sabriya Stukes?

A warm intro from a founder SOSV backed works best. A short LinkedIn note with one line on traction is the next best route.

What did Sabriya Stukes do before SOSV?

founding Associate Director for the Master’s in Translational Medicine (MTM) program at The City College of New York; Operations Director at Stellate Therapeutics; Partner at SOSV NY.

Last updated 2026-10-15. Is this you? Ask for a correction.